Communiqués HBM Healthcare Investments AG

Actions

HBMN

CH0012627250

Gestion des placements et exploitants de fonds

Marché Fermé - Swiss Exchange Autres places de cotation 17:31:44 08/06/2026			Varia. 5j.	Varia. 1 janv.
233,50 ^CHF	0,00%		-2,30%	+3,09%

01/06	HBM finalise la cession de parts dans Swixx Biopharma	AW
01/06	HBM Healthcare Investments finalise la cession d'une participation dans Swixx Biopharma	MT

Communiqués

01/06	Key Figures 31.05.2026	EQ
01/06	HBM Healthcare Investments Announces Closing of Swixx Biopharma Transaction with SK Capital and Bain Capital Life Sciences	EQ
26/05	Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion	EQ
22/05	HBM Healthcare Investments : Invitation to Ordinary Shareholders' Meeting of 15.6.2026	PU
18/05	Key Figures 15.05.2026	EQ
13/05	HBM Healthcare Investments posts profit of CHF 272 million in its 25th financial year	EQ
01/05	Key Figures 30.04.2026	EQ
16/04	Key Figures 15.04.2026	EQ
01/04	HBM Healthcare Investments increases NAV by 17.2 percent and expects annual profit of CHF 272 million for the 2025/2026 financial year	EQ
01/04	Key Figures 31.03.2026	EQ
25/03	Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion	EQ
16/03	Key Figures 15.03.2026	EQ
02/03	Key Figures 28.02.2026	EQ
16/02	Key Figures 15.02.2026	EQ
02/02	Key Figures 31.01.2026	EQ
23/01	HBM Healthcare Investments publishes Quarterly Report as at 31 December 2025 with key figures for the first nine months of the 2025/2026 financial year	EQ
23/01	HBM Healthcare Investments : Quarterly Report December 2025	PU
16/01	Key Figures 15.01.2026	EQ
05/01	HBM Healthcare Investments once again delivered strong value growth in the 2025 calendar year despite currency headwind	EQ
05/01	Key Figures 31.12.2025	EQ
16/12	Key Figures 15.12.2025	EQ
15/12	HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma	EQ
08/12	Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million	EQ
01/12	Key Figures 30.11.2025	EQ
17/11	Key Figures 15.11.2025	EQ